Medincell (Euronext Paris: MEDCL), a commercial- and clinical-stage biopharmaceutical licensing company developing long-acting injectable treatments, today announced that Christophe Douat, Chief ...
IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of ...
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will attend the ...
Palantir's strong earnings failed to sway prominent bears, including Michael Burry. Meanwhile, Jefferies downgraded the stock to "underweight" this week.
Jefferies initiated coverage of Pershing Square USA (PSUS) with a Buy rating and Pershing Square Inc. (PS) with a Hold ...
Jefferies has increased its target price for Belrise Industries to Rs 250, maintaining a positive outlook. The auto component ...
Former CFTC chair “crypto dad” Christopher Giancarlo joins Jefferies as senior adviser in July, boosting its digital-asset ...
The Downside of SIPs,” the brokerage argued that heavy foreign selling in Indian equities, combined with strong domestic ...
JEFFERIES Financial Group has appointed Gideon Volschenk from Standard Chartered to lead its metals and mining banking team ...
Mahesh Nandurkar, MD & Head of India Research at Jefferies India says India’s valuation premium and the global artificial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results